Danish medical journal · 2025
Post-operative care and complications following transoral robotic surgery for obstructive sleep apnoea.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mølhave Martin, Svanesøe Sara, Aggerholm Winnie, Bertelsen Jannik Buus, Zainali-Gill Kasra
Аннотация
INTRODUCTION: Transoral robotic surgery for base-of-tongue reduction (TORS-BOT) is an effective treatment for obstructive sleep apnoea (OSA) in patients with tongue base collapse and lingual tonsil hypertrophy. However, post-operative complications may considerably affect recovery. This study evaluated post-operative outcomes, particularly dysphagia, pain management and nutritional challenges, in a Danish cohort.
METHODS: This retrospective cohort study included patients who underwent TORS-BOT at a single Danish centre between April 2022 and September 2024. Data were extracted from electronic medical records. Outcomes included dysphagia, pain management, nasogastric tube (NGT) use and infection rates.
RESULTS: Forty patients, primarily middle-aged, overweight males, underwent TORS-BOT. Most also received additional sleep surgery procedures. The median hospital stay was 3.5 days. Readmission occurred in 20%, mainly due to pain, infection or bleeding. More than 80% experienced complications, with dysphagia (70%) being the most common, often requiring NGT support. Pain control was frequently insufficient, resulting in impaired oral intake. Constipation was prevalent (68%), whereas laxative prophylaxis was inconsistent. Antibiotics were administered to 40%, mainly for aspiration pneumonia.
CONCLUSIONS: Post-operative dysphagia, pain and nutritional issues were common after TORS-BOT for OSA. Standardised post-operative protocols focusing on pain management, dysphagia interventions and nutritional support are needed.
FUNDING: None.
TRIAL REGISTRATION: Not relevant.
METHODS: This retrospective cohort study included patients who underwent TORS-BOT at a single Danish centre between April 2022 and September 2024. Data were extracted from electronic medical records. Outcomes included dysphagia, pain management, nasogastric tube (NGT) use and infection rates.
RESULTS: Forty patients, primarily middle-aged, overweight males, underwent TORS-BOT. Most also received additional sleep surgery procedures. The median hospital stay was 3.5 days. Readmission occurred in 20%, mainly due to pain, infection or bleeding. More than 80% experienced complications, with dysphagia (70%) being the most common, often requiring NGT support. Pain control was frequently insufficient, resulting in impaired oral intake. Constipation was prevalent (68%), whereas laxative prophylaxis was inconsistent. Antibiotics were administered to 40%, mainly for aspiration pneumonia.
CONCLUSIONS: Post-operative dysphagia, pain and nutritional issues were common after TORS-BOT for OSA. Standardised post-operative protocols focusing on pain management, dysphagia interventions and nutritional support are needed.
FUNDING: None.
TRIAL REGISTRATION: Not relevant.